The growth and management of R&D outsourcing: Evidence from UK pharmaceuticals

R and D Management

Volumn 38, Issue 2, 2008, Pages 205-219

  Howells, Jeremy ^a   Gagliardi, Dimitri ^a   Malik, Khaleel ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 39449136530     PISSN: 00336807     EISSN: 14679310     Source Type: Journal    
DOI: 10.1111/j.1467-9310.2008.00508.x     Document Type: Article

References (53)

1. Alchian, A.A. Demsetz, H. (1972) Production, information costs and economic organization. American Economic Review, 62, 777 795.
2. Arora, A. Gambardella, A. (1990) Complementarity and external linkages: the strategies of the large firms in biotechnology. Journal of Industrial Economics, 38, 361 379.
3. Arrow, K.J. (1962) Economic welfare and the allocation of resources for inventions. In Nelson, R. (ed.), The Rate and Direction of Inventive Activity. Princeton : Princeton University Press, pp. 609 625.
4. Carter, A.P. (1989) Knowhow trading as economic exchange. Research Policy, 18, 155 163.
5. Cavusgil, S.T., Calantone, R.J. Zhao, Y. (2003) Tacit knowledge transfer and firm innovation capability. Journal of Business & Industrial Marketing, 18, 6 21.
6. Cohen, W.M. Levinthal, D.A. (1990) Absorptive capacity: a new perspective on learning and innovation. Administrative Science Quarterly, 35, 128 152.
7. Coombs, R. (1996) Core competencies and the strategic management of R&D. R&D Management, 26, 345 355.
8. Coombs, R. Metcalfe, J.S. (2002) Innovation in pharmaceuticals: perspectives on coordination, combination and creation of capabilities. Technology Analysis and Strategic Management, 14, 261 271.
9. De Laat, P.B. (1999) Dangerous liaisons: sharing knowledge within research and development alliances. In Grandori, A. (ed.), Interfirm Networks: Organization and Industrial Competitiveness. London : Routledge, pp. 208 233.
10. Della Valle, F. Gambardella, A. (1993) Biological revolution and strategies for innovation in pharmaceutical companies. R&D Management, 23, 287 302.
11. DiMasi, J.A., Hansen, R.W. Grabowski, H.G. (2003) The price of innovation: new estimates of drug development costs. Journal of Health Economics, 22, 151 185.
12. Doctor, R.N., Newton, D.P. Pearson, A. (2001) Managing uncertainty in research and development. Technovation, 21, 79 90.
13. Ford, D. Farmer, D. (1986) Make or buy - a key strategic issue. Long Range Planning, 19, 54 62.
14. Freeman, C. Soete, L. (1997) The Economics of Industrial Innovation, 3rd edn. London : Pinter.
15. Galambos, L. Sturchio, J. (1996) The pharmaceutical industry in the twentieth century: a reappraisal of the sources of innovation. History and Technology, 13, 83 100.
16. Groenewegen, P. Wouters, P. (2004) Genomics, ICT and the formation of R&D networks. Genetics and Society, 23, 167 185.
17. Hagedoorn, J. (1993) Understanding the rationale of strategic technology partnering: interorganizational modes of cooperation and sectoral differences. Strategic Management Journal, 24, 371 385.
18. Howells, J. (1996) Tacit knowledge, innovation and technology transfer. Technology Analysis and Strategic Management, 8, 91 106.
19. Howells, J. (1999) Research and technology outsourcing. Technology Analysis and Strategic Management, 11, 591 603.
20. Howells, J. (2002) Mind the gap: information and communication technologies, knowledge activities and innovation in the pharmaceutical industry. Technology Analysis and Strategic Management, 14, 335 370.
21. Howells, J. (2006) Outsourcing for innovation: systems of innovation and the role of knowledge intermediaries. In Miozzo, M. Grimshaw, D. (eds.), Knowledge Intensive Business Services: Organizational Forms and National Institutions, Edward Elgar, Cheltenham, pp. 61 81.
22. Howells, J., James, A. Malik, K. (2003) The sourcing of technological knowledge: distributed innovation processes and dynamic change. R&D Management, 33, 395 409.
23. Howells, J. Neary, I. (1995) Intervention and Technological Innovation: Government and the Pharmaceutical Industry in the UK and Japan. London : Macmillan.
24. Jones, O. (2000) Innovation management as a post-modern phenomenon: the outsourcing of pharmaceutical R&D. British Journal of Management, 11, 341 356.
25. Liebenau, J.M. (1984) International R&D in pharmaceutical firms in the early twentieth century. Business History, 26, 329 346.
26. Lim, P.L.L., Garnsey, E. Gregory, M. (2006) Product and process innovation in biopharmaceuticals - a new perspective on development. R&D Management, 36, 27 36.
27. Lowe, J. Taylor, P. (1998) R&D and technology purchase through licence agreements: complementary strategies and complementary assets. R&D Management, 28, 263 278.
28. Madhavan, R., Koka, B.R. Prescott, J.E. (1998) Networks in transition: how industry events (re)shape interfirm relationships. Strategic Management Journal, 19, 439 459.
29. McKelvey, M. (1995) Evolutionary Innovation: The Business of Biotechnology. Oxford : Oxford University Press.
30. McKelvey, M., Alm, H. Riccabani, M. (2001) Does co-location matter? Knowledge collaboration in the Swedish biotechnology-pharmaceutical sector. ESSY Working Paper, Chalmers, Gothenburg.
31. Mikkola, J.H. (2003) Modularity, component outsourcing, and inter-firm learning. R&D Management, 33, 439 454.
32. Mittra, J. (2003) Innovation processes in genomics industry sectors. Innogen Working Paper No. 5, ESRC Centre for Social and Economic Research on Innovation in Genomics, University of Edinburgh.
33. Mowery, D.C. (1984) Firm structure, government policy, and the organization of industrial research: Great Britain and the United States, 1900-1950. Business History Review, 58, 504 531.
34. Nelson, R.R. Winter, S.G. (1982) An Evolutionary Theory of Economic Change. Cambridge, MA : Harvard University Press.
35. Nightingale, P.L. (2000) Economies of scale in experimentation: knowledge and technology in pharmaceutical R&D. Industrial and Corporate Change, 9, 315 359.
36. Office for National Statistics (2007) Research and Development in UK Businesses, 2005. Business Monitor (MA14). Norwich : HMSO.
37. Orsenigo, L. (1989) The Emergence of Biotechnology. London : Pinter.
38. Orsenigo, L., Pammolli, F. Riccaboni, M. (2001) Technological change and network dynamics: lessons from the pharmaceutical industry. Research Policy, 30, 485 508.
39. Pisano, G.P. (1994) Knowledge, integration and the locus of learning: an empirical analysis of process development. Strategic Management Journal, 15, 85 100.
40. Pisano, G.P., Shaw, W. Teece, D.J. (1988) Joint ventures and collaboration in the biotechnology industry In Mowery, D.C. (ed.), International Collaborative Ventures in U.S. Manufacturing, Ballinger, Cambridge, MA, pp. 182 222.
41. Powell, W.W. (1998) Learning from collaboration: knowledge and networks in the biotechnology and pharmaceutical industries. California Management Review, 40, 228 240.
42. Powell, W.W., Koput, K.K. Smith-Doerr, L. (1996) Inter-organisational collaboration and the locus of innovation: network learning in biotechnology. Administrative Science Quarterly, 41, 116 145.
43. Prahalad, C. Hamel, G. (1990) The core competence of the corporation. Harvard Business Review, 68, 79 91.
44. Sanderson, M. (1972) Research and the firm in British industry, 1919-39. Science Studies, 2, 107 151.
45. Schein, R. Williams, R. (2002) Chemistry, manufacturing, and controls information in NDAs and ANDAs, supplements, Annual Reports, and other regulatory filings. Pharmaceutical Research, 19, 217 226.
46. Shan, W., Walker, G. Kogut, B. (1994) Interfirm cooperation and start-up innovation in the biotechnology industry. Strategic Management Journal, 15, 387 394.
47. Studt, T. (2003) Knowledge management is key to improving drug R&D cycles. R&D Magazine April, 18.
48. Sutcliffe, K.M. Zaheer, A. (1998) Uncertainty in the transaction environment: an empirical test. Strategic Management Journal, 19, 1 23.
49. Thomke, S. Kuemmerle, W. (2002) Asset accumulation, interdependence and technological change: evidence from pharmaceutical drug discovery. Strategic Management Journal, 23, 619 635.
50. Walsh, V., Niosi, J. Mustar, P. (1995) Small-firm formation in biotechnology: a comparison of France, Britain and Canada. Technovation, 15, 303 327.
51. Welch, J.A. Nayak, P.R. (1992) Strategic sourcing. Academy of Management Executive, 6, 23 31.
52. Whittaker, E. Bower, D.J. (1994) A shift to external alliances for product development in the pharmaceutical industry. R&D Management, 24, 249 260.
53. Winter, S. (1987) Knowledge and competence as strategic assets. In Teece, D. (ed.), The Competitive Challenge: Strategies for Industrial Innovation and Renewal, Ballinger, Cambridge, MA, pp. 159 183.